Flexion Therapeutics (NASDAQ:FLXN) : The money flow analysis of Flexion Therapeutics (NASDAQ:FLXN) indicates a $1.8 million of outflow was on downticks, whereas, the investors on Wednesday gobbled up stocks worth $2.36 million on upticks. The ratio between the upticks and downticks was clearly in favor of the bulls at 1.31 and so was the total money flow at $0.55 million. The bulls lapped up $0.15 million worth of block trades on upticks. The money flow was $0.15 million in block trades, underlining the interest of the bulls in the stock even when the stock was declining.However, the price action shows that the bears had an upper hand in the stock of Flexion Therapeutics (NASDAQ:FLXN), pushing it down by -1.33% for the day. The stock slid $0.2 and traded at $14.88 during the day. Nonetheless, the stock is 6.82% over the previous weeks close.
In an insider trading activity, Colella Samuel D, director 10% owner of Flexion Therapeutics Inc, executed a transaction worth $350,425 on June 20, 2016. A total of 25,504 shares were purchased at an average price of $13.74. The Insider information was divulged by the Securities and Exchange Commission in a Form 4 filing. The information is based on open market trades at the market prices.Option exercises are not covered. Currently the company Insiders own 18% of Flexion Therapeutics shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by 26.6% . Institutional Investors own 49.91% of Flexion Therapeutics shares. During last six month period, the net percent change held by insiders has seen a change of 26.6%.
The company shares have dropped -30.12% from its 1 Year high price. On Sep 8, 2015, the shares registered one year high at $29.09 and the one year low was seen on Mar 17, 2016. The 50-Day Moving Average price is $13.22 and the 200 Day Moving Average price is recorded at $12.99. Flexion Therapeutics (NASDAQ:FLXN): The stock opened at $15.53 on Wednesday but the bulls could not build on the opening and the stock topped out at $15.81 for the day. The stock traded down to $14.52 during the day, due to lack of any buying support eventually closed down at $14.88 with a loss of -1.33% for the day. The stock had closed at $15.08 on the previous day. The total traded volume was 519,876 shares.
Flexion Therapeutics, Inc. is a specialty pharmaceutical company focused on the development and commercialization of injectable pain therapies. The Company is also focused on anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions, such as osteoarthritis (OA), a type of degenerative arthritis. The Companys portfolio of product candidates addresses the OA pain treatment spectrum, from moderate to severe pain. The Companys products include FX006, which is indicated for front line intra-articular (IA) therapy for patients with moderate to severe OA pain; FX007, which is indicated for post-operative pain, and FX005, which is indicated for end-stage OA pain. The Company is conducting a pivotal Phase IIb clinical trial of FX006. The Company is conducting preclinical local pharmacology and toxicology experiments of FX007. FX005 has completed its Phase IIa trials.